A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive-fibrosing interstitial lung disease of unknown origin that affects 3 million people worldwide and imparts substantial burdens to patients, ...
Idiopathic pulmonary fibrosis (IPF), also known as cryptogenic fibrosing alveolitis, is a health condition involving the progressive scarring and thickening of the lungs. This occurs without a known ...
Un grupo de investigadores del National Jewish Health e instituciones colaboradoras (EEUU) ha descubierto un mecanismo crucial que impulsa la fibrosis pulmonar persistente y ha identificado una ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
Over time, rheumatoid arthritis (RA) can lead to lung tissue damage, which can result in a condition doctors call pulmonary fibrosis. With this condition, lung tissue becomes thick and scarred, making ...
Washington, 31 mar (Prensa Latina) Los resultados de una investigación trazan hoy una vía para revertir la fibrosis pulmonar a partir de la proteína BCL-2. Este mecanismo fue descubierto por un grupo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results